查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1373939

肝素市场，按类型、来源、按应用、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Heparin Market, By Type, By Source, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年肝素市场规模为95.3亿美元，2023年至2030年复合CAGR为4.2%。

肝素市场-市场动态

肝素预防和治疗血栓的功效推动市场需求

肝素是一种强效抗凝血​​剂，在需要立即预防或溶解血栓的情况下（包括外科手术、心臟干预以及深部静脉栓塞和肺栓塞等疾病的治疗），是一种快速且不可或缺的药物。肝素在预防和治疗方面的广泛应用，增强了患者的安全并提高了各种医疗场景中的治疗效果。其独特之处在于其适应性和快速适应不断变化的条件的能力，即使在潜在出血併发症的情况下也能确保患者的健康。

肝素市场-关键洞察

根据我们的研究分析师分享的见解，预计 2023 年至 2030 年期间，全球肝素市场将呈现约 4.2% 的稳定年增长率。

市场的动力可归因于肝素在预防和治疗血栓方面公认的有效性，使其成为医疗实践的关键组成部分。

从细分来看，普通肝素（UFH）在 2022 年成为主导类别，反映了其庞大的市场份额。此外，在来源类别中，猪源肝素在 2022 年占据领先地位。

从地区来看，亚太地区成为 2022 年市场收入的主要贡献者。推动该地区市场成长的多种因素凸显了其在全球舞台上的重要性。

肝素市场細項分析：

全球肝素市场根据类型、来源、应用和地区进行细分。在这个市场模式中，我们发现类型细分下有两个主要类别：普通肝素、低分子量肝素 (LMWH) 和超低分子量肝素 (ULMWH)。

在这些类别中，普通肝素（UFH）成为市场的主导力量。 UFH 作为抗凝血剂在各种医疗环境中发挥至关重要的作用，包括外科手术、心臟介入和血栓性疾病的治疗。其广泛使用归因于它能够透过预防或治疗潜在危险的血栓来确保患者安全。

肝素市场-地理洞察

全球肝素市场的影响力遍及北美、拉丁美洲、欧洲、亚太地区、中东和非洲等不同地区。每个区域进一步细分为积极参与市场活动的国家。

亚太地区是肝素的重要成长中心，受多种因素影响，需求不断上升。该地区人口老化导致需求激增。此外，心血管疾病、深部静脉栓塞和其他血栓相关疾病的激增加剧了该地区对肝素的需求。这些动态凸显了肝素在解决健康问题方面日益重要的意义。

肝素市场-竞争格局：

肝素市场的竞争格局以几家在行业中具有影响力的知名企业的存在为标誌。辉瑞（Pfizer）、赛诺菲（Sanofi）和费森尤斯卡比（Fresenius Kabi）等着名製药巨头凭藉其广泛的产品范围和全球影响力占据了巨大的市场份额。这些主要参与者提供多种肝素配方，以满足各种医疗应用的要求。此外，市场上还有仿製药製造商的参与，他们努力透过提供具有成本效益的替代品来获得竞争优势。

目录

第 1 章：肝素市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的肝素市场片段
    • 肝素市场来源摘要
    • 肝素市场片段（依应用）
    • 按国家/地区分類的肝素市场片段
    • 按地区分類的肝素市场片段
  • 竞争洞察

第 3 章：肝素主要市场趋势

  • 肝素市场驱动因素
    • 市场驱动因素的影响分析
  • 肝素市场限制
    • 市场限制影响分析
  • 肝素市场机会
  • 肝素市场未来趋势

第 4 章：肝素产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：肝素市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：肝素市场格局

  • 2022 年肝素市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：肝素市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 普通肝素
    • 低分子肝素 (LMWH)
    • 超低分子肝素 (ULMWH)

第 8 章：肝素市场 - 按来源

  • 概述
    • 按来源分類的细分市场占有率分析
    • 牛科
    • 猪

第 9 章：肝素市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 深部静脉血栓 (DVT)
    • 心房颤动和心臟病发作
    • 冠状动脉疾病
    • 其他应用

第 10 章：肝素市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美肝素主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模与预测（按来源）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲肝素主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模与预测（按来源）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区肝素主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按来源）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲肝素主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按来源）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲肝素主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按来源）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 肝素产业

  • 竞争仪表板
  • 公司简介
    • Pfizer
    • Sanofi
    • Fresenius Kabi
    • Aspen Pharmacare
    • LEO Pharma
    • Teva Pharmaceuticals
    • Amphastar Pharmaceuticals
    • Baxter International
    • GlaxoSmithKline (GSK)
    • B. Braun Melsungen AG
    • Mylan
    • Sandoz
    • Leo Pharma
    • Pfizer
    • Hikma Pharmaceuticals

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1815

REPORT HIGHLIGHT

Heparin Market size was valued at USD 9,530 Million in 2022, expanding at a CAGR of 4.2 % from 2023 to 2030.

Heparin is a highly efficient anticoagulant employed in the medical field to prevent the formation of blood clots. This versatile substance can be derived from animal tissues or synthetically synthesized. Its mechanism of action involves the inhibition of critical blood clotting factors like thrombin and factor Xa, effectively reducing the risk of dangerous blood clot development. Heparin administration typically involves injections and plays a vital role in various therapeutic scenarios, such as surgical procedures, dialysis, and the management of conditions like deep vein thrombosis. What sets heparin apart is its rapid onset and the ability to reverse its effects, making it a crucial tool in the treatment of thrombotic disorders. Nevertheless, the precise dosage and monitoring are essential to prevent potential bleeding complications, underscoring its significance in modern medical practice.

Heparin Market- Market Dynamics

Heparin's efficacy in preventing and treating blood clots propel market demand

Heparin, a potent anticoagulant, serves as a rapid and indispensable agent in situations demanding immediate clot prevention or dissolution, including surgical procedures, cardiac interventions, and the management of ailments like deep vein thrombosis and pulmonary embolism. The widespread applicability of heparin, spanning both preventive and therapeutic purposes, enhances patient safety and elevates treatment outcomes in various medical scenarios. Its unique feature lies in its adaptability and the ability to swiftly adapt to changing conditions, ensuring patient well-being even in cases of potential bleeding complications.

Heparin Market- Key Insights

According to insights shared by our research analyst, the global Heparin market is poised to exhibit a steady annual growth rate of approximately 4.2% during the projected period from 2023 to 2030.

The market's momentum can be attributed to Heparin's well-established effectiveness in the prevention and treatment of blood clots, making it a pivotal component of medical practice.

In terms of segmentation, Unfractionated Heparin (UFH) emerged as the dominant category in 2022, reflecting its significant market share. Additionally, within the Source category, Porcine-derived Heparin held a leading position in 2022.

Regionally, Asia Pacific emerged as the primary contributor to market revenues in 2022. The diverse factors driving market growth in this region highlight its significance on the global stage.

Heparin Market- Segmentation Analysis:

The global Heparin Market exhibits a segmentation based on Type, Source, Application, and Region. Within this market landscape, we find two primary categories under the Type segment: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH).

Of these categories, Unfractionated Heparin (UFH) emerges as the dominant force in the market. UFH plays a vital role as an anticoagulant in various medical settings, including surgical procedures, cardiac interventions, and the management of thrombotic disorders. Its widespread use is attributed to its capacity to ensure patient safety by preventing or treating potentially dangerous blood clots.

Heparin Market- Geographical Insights

The global Heparin Market extends its influence across diverse regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Each of these regions is further subdivided into countries that actively engage in market activities.

The Asia-Pacific region stands out as a significant growth hub for Heparin, with escalating demand influenced by various factors. The region's aging demographic contributes to this demand surge. Moreover, an upsurge in cardiovascular diseases, deep vein thrombosis, and other clot-related conditions has fueled the need for Heparin in this region. These dynamics underline the growing significance of Heparin in addressing health concerns.

Heparin Market- Competitive Landscape:

The competitive landscape within the Heparin market is marked by the presence of several notable players who exert influence in the industry. Prominent pharmaceutical giants like Pfizer, Sanofi, and Fresenius Kabi occupy substantial market share due to their extensive range of products and global presence. These major players offer diverse Heparin formulations tailored to cater to the requirements of various medical applications. Additionally, the market sees participation from generic pharmaceutical manufacturers who strive to gain a competitive edge by presenting cost-effective alternatives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPARIN MARKET KEY PLAYERS

  • Pfizer
  • Sanofi
  • Fresenius Kabi
  • Aspen Pharmacare
  • LEO Pharma
  • Teva Pharmaceuticals
  • Amphastar Pharmaceuticals
  • Baxter International
  • GlaxoSmithKline (GSK)
  • B. Braun Melsungen AG
  • Mylan
  • Sandoz
  • Leo Pharma
  • Pfizer
  • Hikma Pharmaceuticals

GLOBAL HEPARIN MARKET, BY TYPE

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMWH)

GLOBAL HEPARIN MARKET, BY SOURCE

  • Bovine
  • Porcine

GLOBAL HEPARIN MARKET, BY APPLICATION

  • Deep Vein Thrombosis (DVT)
  • Atrial Fibrillation and Heart Attack
  • Coronery Artery Disease
  • Other Applications

GLOBAL HEPARIN MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Heparin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Heparin Market Snippet by Type
    • 2.1.2. Heparin Market Snippet by Source
    • 2.1.3. Heparin Market Snippet by Application
    • 2.1.4. Heparin Market Snippet by Country
    • 2.1.5. Heparin Market Snippet by Region
  • 2.2. Competitive Insights

3. Heparin Key Market Trends

  • 3.1. Heparin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Heparin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Heparin Market Opportunities
  • 3.4. Heparin Market Future Trends

4. Heparin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Heparin Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Heparin Market Landscape

  • 6.1. Heparin Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Heparin Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Unfractionated Heparin
    • 7.1.3. Low Molecular Weight Heparin (LMWH)
    • 7.1.4. Ultra-low Molecular Weight Heparin (ULMWH)

8. Heparin Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
    • 8.1.2. Bovine
    • 8.1.3. Porcine

9. Heparin Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Deep Vein Thrombosis (DVT)
    • 9.1.3. Atrial Fibrillation and Heart Attack
    • 9.1.4. Coronery Artery Disease
    • 9.1.5. Other Applications

10. Heparin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Heparin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Heparin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Heparin Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Heparin Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Heparin Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Heparin Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer
    • 11.2.2. Sanofi
    • 11.2.3. Fresenius Kabi
    • 11.2.4. Aspen Pharmacare
    • 11.2.5. LEO Pharma
    • 11.2.6. Teva Pharmaceuticals
    • 11.2.7. Amphastar Pharmaceuticals
    • 11.2.8. Baxter International
    • 11.2.9. GlaxoSmithKline (GSK)
    • 11.2.10. B. Braun Melsungen AG
    • 11.2.11. Mylan
    • 11.2.12. Sandoz
    • 11.2.13. Leo Pharma
    • 11.2.14. Pfizer
    • 11.2.15. Hikma Pharmaceuticals

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Heparin Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Heparin Market, by Type 2018-2030 (USD Million)
  • TABLE Heparin Market: Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Heparin Market, by Source 2018-2030 (USD Million)
  • TABLE Heparin Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Heparin Market, by Application 2018-2030 (USD Million)
  • TABLE Heparin Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Heparin Market, by Region 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Application, 2018-2030 (USD Million)